System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Marc-André Mahé is an expert in Radiotherapy at Institut de Cancérologie de l'Ouest (France). Marc-André Mahé has authored 189 publications, the most recent in 2023, and is an investigator in 5 clinical trials. SLR score: 480 (community average: 125). How the SLR is computed.

LeadR Profile

Marc-André Mahé Institut de Cancérologie de l'Ouest France
480 ScienceLeadR Reputation 480

Unlock

Register Login
Network Map

Radiotherapy

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1994 - 2023
Source: PubMed

Institut de Cancérologie de l'Ouest

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 189

Citations

Citations: 2 401 1st author: 22 Last author: 38 Unique author: 0

Main journals

Cancer Radiother 94
Int J Radiat Oncol Biol Phys 26
Radiother Oncol 15
J Clin Oncol 6
Radiat Oncol 5

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.
PMID 38111609 — risk, prostate, prostatic neoplasms, disease-free survival, radiotherapy		Clin Transl Radiat Oncol20233
Preoperative Radiotherapy with a Simultaneous Integrated Boost Compared to Chemoradiotherapy for cT3-4 Rectal Cancer: Long-Term Results of a Multicenter Randomized Study.
PMID 37568685 — rectal neoplasms, disease-free survival, radiotherapy, chemoradiotherapy, progression-free survival		Cancers (Basel)20231
Phase 1 Study of the Combination of Escalated Total Marrow Irradiation Using Helical Tomotherapy and Fixed High-Dose Melphalan (140 mg/m²) Followed by Autologous Stem Cell Transplantation at First Relapse in Multiple Myeloma.
PMID 36174802 — melphalan, stem cells, microscopy, electron, scanning transmission, stem cell transplantation, radiobiology, multiple myeloma, mucositis, chemotherapy		Int J Radiat Oncol Biol Phys20228
Treatment related factors associated with the risk of breast radio-induced-sarcoma.
PMID 35405175 — radiotherapy, breast neoplasms, neoplasms, sarcoma, breast, therapeutics, medical oncology		Radiother Oncol202215
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study.
PMID 35087753 — risk, prostate, therapeutics, prostatic neoplasms, prospective studies, propensity score		Front Oncol20221

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 1 1
Phase 2 1
Phase 3 1

By status:

Completed 3
Unknown 2

By type:

Interventional 4
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 1
multicentric5to9 1
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS